Our goal is to bring the best treatments at an affordable cost to the patients’ world over. We develop and manufacture drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis and other infectious disease drug segments for our institutional business. Our customers for this business segment include institutionally-funded aid projects and global procurement agencies. As one of the leading Indian suppliers of drugs in these segments, we are at the forefront in the fight against these global pandemics.

Today, we are an approved supplier to Institutionally-funded aid projects and Global Procurement Agencies like USAID, Global Fund, PEPFAR (The US President’s Emergency Plan for AIDS Relief), UNICEF, WHO, Pan American Health Organization (PAHO), United Nations Development Program(UNDP), Population Services International (PSI), Chemeonics, PFSCM, amongst others. Our products are supplied to disease-prone regions in Africa, Asia and Latin America with distribution to over 100 countries.

We manufacture our Institutional range of products at our world-class facilities in Bangalore that comply with stringent regulatory standards and have regulatory approvals from the US-FDA, MHRA, TGA and WHO. We are also capitalising on our WHO-approved manufacturing facility in Kenya for global donor agencies and local government tenders in Africa. We continue to strengthen our R&D initiatives to develop next-generation products and are also collaborating with agencies like UNITAID, Medicines Malaria Venture (MMV) and licensing agreements with Medicines Patent Pool (MPP), Gilead Life Sciences, Vive amongst others.